Healthcare News
New therapies for rheumatoid arthritis, including Janus kinase (JAK) inhibitors and Bruton’s tyrosine kinase (BTK) inhibitors, hold promise in reducing inflammation and alleviating symptoms. Experimental approaches like vagus nerve stimulation are also being explored to further improve patient outcomes.
Source: Verywell health
